Theme hub · 46 companies
Pharmaceuticals large cap stocks
Heavily traded in Pharmaceuticals large cap
Turnover over $10M/day32 of about 50 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| JNJJohnson & Johnson | $1.72B | +50.06% | — |
| ABBVAbbVie Inc. | $1.28B | +31.28% | Reports Oct 30, 2026 |
| NVSNovartis AG | $277.31M | +36.29% | — |
| AMGNAmgen Inc. | $1.18B | +61.35% | Reports Nov 3, 2026 |
| GILDGilead Sciences, Inc. | $884.32M | +41.48% | — |
| PFEPfizer Inc. | $895.37M | +29.68% | Reports Nov 3, 2026 |
| SNYSanofi | $112.10M | −10.18% | Reports Oct 30, 2026 |
| GSKGSK plc | $160.55M | +8.76% | — |
JNJ+50.06%$1.72BView analysisABBV+31.28%$1.28BReports Oct 30, 2026Pre-earnings analysisNVS+36.29%$277.31MView analysisAMGN+61.35%$1.18BReports Nov 3, 2026Pre-earnings analysisGILD+41.48%$884.32MView analysisPFE+29.68%$895.37MReports Nov 3, 2026Pre-earnings analysisSNY−10.18%$112.10MReports Oct 30, 2026Pre-earnings analysisGSK+8.76%$160.55MView analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
46 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | $662.49B | Mega cap | +50.06% |
| ABBV34.SA | AbbVie Inc. | $534.28B | Mega cap | +36.63% |
| ABBV | AbbVie Inc. | $513.86B | Mega cap | +31.28% |
| 0TDF.L | Roche Holding AG | $343.63B | Mega cap | +32.09% |
| NVS | Novartis AG | $304.26B | Mega cap | +36.29% |
| AMGN | Amgen Inc. | $249.09B | Mega cap | +61.35% |
| AMGN34.SA | Amgen Inc. | $248.85B | Mega cap | +60.37% |
| GILD | Gilead Sciences, Inc. | $205.35B | Mega cap | +41.48% |
| PFE | Pfizer Inc. | $170.71B | Large cap | +29.68% |
| BMYB34.SA | Bristol-Myers Squibb Company | $122.82B | Large cap | +42.65% |
| SNY | Sanofi | $101.21B | Large cap | −10.18% |
| GSK | GSK plc | $97.53B | Large cap | +8.76% |
| SAN.PA | Sanofi | $95.34B | Large cap | −13.40% |
| REGN | Regeneron Pharmaceuticals, Inc. | $84.30B | Large cap | +25.90% |
| CSL.AX | CSL Limited | $66.70B | Large cap | +11.41% |
| MRK.DE | Merck KGaA | $66.19B | Large cap | +30.36% |
| 4502.T | Takeda Pharmaceutical Company Limited | $65.47B | Large cap | +50.74% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $64.64B | Large cap | +43.85% |
| TAK | Takeda Pharmaceutical Company Limited | $64.37B | Large cap | +45.32% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.77B | Large cap | +47.75% |
| 4503.T | Astellas Pharma Inc. | $28.54B | Large cap | +58.68% |
| 4507.T | Shionogi & Co., Ltd. | $16.11B | Large cap | +21.75% |
| 0D53.L | Financière de Tubize SA | $11.36B | Large cap | −25.23% |
| OGN | Organon & Co. | $3.62B | Mid cap | +119.28% |
| 2784.T | Alfresa Holdings Corporation | $2.75B | Mid cap | +14.27% |
| 4540.T | Tsumura & Co. | $1.78B | Small cap | +6.49% |
| INVA | Innoviva, Inc. | $1.54B | Small cap | +21.29% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $911.54M | Small cap | +6.17% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $872.92M | Small cap | −26.67% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $730.05M | Small cap | +10.62% |
| AMRN | Amarin Corporation plc | $535.41M | Small cap | −24.24% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | $358.09M | Small cap | −3.18% |
| DERM | Journey Medical Corporation | $152.69M | Small cap | −31.86% |
| MYX.AX | Mayne Pharma Group Limited | $144.07M | Small cap | −59.68% |
| PRM.TO | Big Pharma Split Corp A Shares | $14.68M | Micro cap | +31.93% |
| ALK-B.CO | ALK-Abelló A/S | — | Large cap | +11.07% |
| BAVA.CO | Bavarian Nordic A/S | — | Large cap | −0.67% |
| BAYN.DE | Bayer Aktiengesellschaft | — | Large cap | +58.67% |
| C1CO34.SA | Cencora, Inc. | — | Mega cap | −6.75% |
| GSK.L | GSK plc | — | Large cap | +13.59% |
| ILM1.DE | Medios AG | — | Small cap | −20.31% |
| NOVN.SW | Novartis AG | — | — | +22.89% |
| NOVNEE.SW | Novartis AG | — | — | +2.00% |
| RO.SW | Roche Holding AG | — | — | +34.90% |
| ROP.SW | Roche Holding AG | — | — | +39.36% |
| VLA.PA | Valneva SE | — | Small cap | −42.50% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 46 companies grouped under the Pharmaceuticals large cap theme. The median market value in the group is $64.64B. Among the 17 with a price from the latest session, the median move over the past trading day is +1.70%. 60% of the 45 with a 200-day average trade above it. Price change over the past year runs from −24.7% to +54.7% across the middle 80 percent of the group, with a median of +22.3%.
Other lists in this group
Pharmaceuticals large capAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGene therapyGenerative AIGeneric drugsGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNeuroscienceNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOncologyOnline travelPackaged foodsPayment processingPet carePotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare diseaseRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind